Inventor · disambiguated record
Benjamin S. Lane
Also filed as: LANE BENJAMIN · LANE BENJAMIN S · LANE BENJAMIN STEPHEN
12 granted patents·7 pending applications·44 citations·filing 2008–2024
88Inventor score
Files withINFINITY PHARMACEUTICALS INC7NUVALENT INC3SERVIER PHARMACEUTICALS LLC3MILLENNIUM PHARM INC2BIOGEN IDEC INC1
Top patents by PatentIndex Score
19 records- 0193US8809349B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesREN PINGDA·Filed 2012·Granted Aug 19, 2014·26 cites·65 claims
- 0286US11345677B2Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving sameSERVIER PHARMACEUTICALS LLC·Filed 2018·Granted May 31, 2022·1 cites·31 claims
- 0386US9290497B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·6 cites·37 claims
- 0486US2025197400A1Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0583US11312718B2Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-oneINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·1 cites·34 claims
- 0683US2024343705A1Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving sameSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0781US11851417B2Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving sameSERVIER PHARMACEUTICALS LLC·Filed 2022·Granted Dec 26, 2023·0 cites·29 claims
- 0881US9556177B2Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitorsMILLENNIUM PHARM INC·Filed 2014·Granted Jan 31, 2017·4 cites·18 claims
- 0980US8293752B2Compounds useful as Raf kinase inhibitorsCHEN WEIRONG·Filed 2008·Granted Oct 23, 2012·6 cites·13 claims
- 1077US2023108157A1Formulations of (s)-3-(1-(9h-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2h)-oneINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1167US10550122B2Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Feb 4, 2020·0 cites·31 claims
- 1264US2024317771A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2024·Application pending·0 cites
- 1362US12043626B2Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2022·Granted Jul 23, 2024·0 cites·36 claims
- 1462US9840505B2Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 12, 2017·0 cites·31 claims
- 1561USRE46621EProcesses for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 5, 2017·0 cites·66 claims
- 1655US9920048B2Substituted pyrimidines for inhibiting Raf kinase activityMILLENNIUM PHARM INC·Filed 2016·Granted Mar 20, 2018·0 cites·13 claims
- 1750US2023322797A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2023·Application pending·0 cites
- 1848US2010130515A1Polymorphs and solvates of a pharmaceutical and method of makingBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 1942US2010173914A1Pharmaceuticals, compositions and methods of making and using the sameCHANG HEXI·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benjamin S. Lane files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →